Loading…

Predictors of long-term survival in nonagenarians: the NonaSantfeliu study

few studies have prospectively evaluated long-term predictors of mortality in nonagenarians. to determine predictors of death in a nonagenarian cohort after 5 years of follow-up. a prospective community-based study. a community-based study. one hundred and eighty-six nonagenarians both living in the...

Full description

Saved in:
Bibliographic Details
Published in:Age and ageing 2011-01, Vol.40 (1), p.111-116
Main Authors: Formiga, Francesc, Ferrer, Assumpta, Chivite, David, Rubio-Rivas, Manuel, Cuerpo, Sandra, Pujol, Ramón
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:few studies have prospectively evaluated long-term predictors of mortality in nonagenarians. to determine predictors of death in a nonagenarian cohort after 5 years of follow-up. a prospective community-based study. a community-based study. one hundred and eighty-six nonagenarians both living in the community and institutionalised. functional status was determined by the Lawton-Brody and Barthel Indexes (BI) and cognition by the Spanish version of the mental state examination (MEC). The Charlson Index was used to measure comorbidity. Nutritional status was evaluated by the short version of the Mini-Nutritional Assessment questionnaire. mortality after 5 years was 75.53%. Patients who did not survive were significantly older, with lower cognitive and functional performance, with diminished visual acuity, higher comorbidity, high risk of malnutrition, higher number of drugs taken and a higher percentage of patients with the diagnosis of dyslipidaemia, heart failure or previous stroke. Cox regression analysis, identified the Charlson Index (hazard ratio 1.23, 95% CI 1.09-1.37) and MEC (hazard ratio 0.98, 95% CI 0.97-0.99) as independent predictors of mortality after 5 years. better cognitive status and lesser comorbidity at baseline are the best predictors to identify which nonagenarians survived after a 5-year follow-up period.
ISSN:0002-0729
1468-2834
DOI:10.1093/ageing/afq127